Early test of new shot for weight and diabetes
NCT ID NCT07004322
Summary
This early-stage study is testing a new injectable medicine called NNC0519-0130 for people with type 2 diabetes and excess weight. It will measure how the drug moves through the body and check for side effects in 20 Chinese men with overweight or obesity. Participants will receive either the real medicine or a placebo (dummy injection) by chance, and the study will last about 28 weeks while testing up to 7 different doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital, Northern Branch-Phase I
Beijing, Beijing Municipality, 100089, China
Conditions
Explore the condition pages connected to this study.